|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Revenues | ||||
| Financial and taxation solution services | ||||
| Education support services | ||||
| Software and maintenance services | ||||
| Total revenues | ||||
| Pre-IPO advisory services | ||||
| Cost of revenues | ||||
| Gross profit | ||||
| Operating expenses: | ||||
| Selling and marketing | ||||
| General and administrative | ||||
| Goodwill impairment | ||||
| Total operating expenses | ||||
| (Loss) Income from operations | ||||
| Other (expense) income, net | ||||
| Interest income | ||||
| Other (expenses) income: | ||||
| Other income (expense), net | ||||
| Interest income | ||||
| Loss on disposal of subsidiary | ||||
| (Loss) Income before income taxes | ||||
| Income tax expense | ||||
| Net (loss) income | ||||
| Less: Net loss attributable to non-controlling interests | ||||
| Net (loss) income attributable to Lichen International Ltd | ||||
| Other comprehensive income (loss ): | ||||
| Foreign currency translation adjustments | ||||
| Comprehensive (loss) income | ||||
| Less: comprehensive income (loss) attributable to non-controlling interests: | ||||
| Comprehensive loss (income) attributable to the Company | ||||
| Weighted average number of ordinary shares outstanding – diluted (in Shares) | ||||
| Weighted average number of ordinary shares outstanding – basic (in Shares) | ||||
| (Loss) Earnings per ordinary share – diluted (in Dollars per share) | ||||
| (Loss) Earnings per ordinary share – basic (in Dollars per share) | ||||
Loading...